Mei-June Liao

Title: Innovations of Mei-June Liao

Introduction

Mei-June Liao is a notable inventor based in Monmouth Junction, NJ (US). She has made significant contributions to the field of medical technology, particularly in the area of leukocyte recovery and antiviral compositions. With a total of four patents to her name, her work has the potential to impact therapeutic treatments for viral infections.

Latest Patents

One of her latest patents is titled "Recovery of functional human leukocytes from recycled filters." This invention provides a method for recovering functional human leukocytes from blood filters that have been used to deplete leukocyte content from blood-cell suspensions. The method involves isolating leukocytes from filters by back-flushing them with a hemolysis solution, such as cold ammonium chloride, to collect the functional human leukocytes. Another significant patent is for a "Composition containing human alpha interferon species proteins." This invention offers alpha interferon compositions that comprise one or a mixture of selected highly antiviral interferon proteins, characterized by increased anti-viral activity. These compositions can be used therapeutically in treating viral infections, particularly retroviral or hepatitis infections, or as additives to enhance the potency of conventional antiviral agents.

Career Highlights

Throughout her career, Mei-June Liao has worked with various companies, including Interferon Sciences, Inc. and Interferon Science, Inc. Her innovative work in the field of interferon research has positioned her as a key figure in the development of antiviral therapies.

Collaborations

Mei-June has collaborated with notable individuals in her field, including Douglas Testa and Abbas Rashidbaigi. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Mei-June Liao's contributions to medical technology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in therapeutic treatments for viral infections.